Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12
Article in Journal for ImmunoTherapy of Cancer (March 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Immunospot Assessment of T-Cell Responses in Preclinical Tumor Models with Undefined Target Antigens
Book chapter (January 2024)
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses
Article in Molecular Therapy (November 2023)